The W&I product expansion looks to address both historical and future risks with "predictable cost structure" for cyber, environmental, D&O, and crisis management add-on covers.
The Shield MCD test screens for 10 of the most common cancers — bladder, colorectal, breast, prostate, esophageal, gastric, liver, lung, ovarian, and pancreatic — with just a blood draw.
Bruce Ford, Goh Thian Leong, Mark Foster, and Florence Lam Puoy Yin have joined the reinsurance broker as part of its strategic treaty expansion in Asia.
Zurich's cross-border collaboration backs Guinness World Record holder Natalie Dau's "Breaking 8" challenge, channelling funds toward displaced families and marginalised children across Southeast Asia...
The PE firm is said to be considering strategic options for Oona, just over three years after the firm was established through a US$350m equity commitment.
Philippi maintains his MSIG Asia CEO role and has been named chief strategy officer alongside Keisuke Ema, with Norihiro Tanaka succeeding Tetsuya Adachi as chairman of MSIG Asia.
